Managing immune-related adverse events is different from managing the effects of chemotherapy.
Immunotherapy agents have different adverse event profiles than traditional chemotherapy, explained Jarushka Naidoo, MBBCh, an assistant professor of oncology at the Sidney Kimmel Cancer Center at Johns Hopkins University.
Oncology nurses should educate their patients about inflammation, which can be serious when it occurs in the heart or in the brain. Further, if members of a healthcare team are unsure about how to manage the immune-related adverse events, they should contact a specialist immediately.
Cilta-cel Showcases PFS Improvement Following First Relapse In Lenalidomide-Refractory Myeloma
Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse Events
Cancer Vaccine mRNA-4157 Improves Recurrence-Free Survival for Patients With High-Risk Melanoma
Multidisciplinary Teamwork Yields Improvements in HSCT Workflow and Care
2 Clarke Drive
Cranbury, NJ 08512